The numbers don't back up this assertion. Share holder returns for past 5 years is -0.66% p/a, Past ten years 5.43% p/a
Any capital gain would definitely be a bonus given the stock price has halved in the past 5 years.
- Forums
- ASX - By Stock
- NCC
- Ann: Media Release - FY23 Results & Dividend Declaration
Ann: Media Release - FY23 Results & Dividend Declaration, page-10
-
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NCC (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.0¢ |
Change
-0.003(0.67%) |
Mkt cap ! $27.30M |
Open | High | Low | Value | Volume |
37.5¢ | 37.5¢ | 37.0¢ | $195.6K | 526.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 47396 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 48054 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 47396 | 0.370 |
2 | 256500 | 0.365 |
2 | 9588 | 0.360 |
2 | 14830 | 0.355 |
2 | 2929 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 48054 | 1 |
0.380 | 49999 | 1 |
0.385 | 91981 | 1 |
0.420 | 2500 | 1 |
0.430 | 5000 | 1 |
Last trade - 16.10pm 24/09/2024 (20 minute delay) ? |
Featured News
NCC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online